These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 22012247)
1. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Wu Y; Chen Y; Qu R; Lan T; Sang J Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247 [TBL] [Abstract][Full Text] [Related]
2. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells. Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906 [TBL] [Abstract][Full Text] [Related]
3. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells. Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012 [TBL] [Abstract][Full Text] [Related]
4. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900 [TBL] [Abstract][Full Text] [Related]
5. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells. Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826 [TBL] [Abstract][Full Text] [Related]
6. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953 [TBL] [Abstract][Full Text] [Related]
7. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells. Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186 [TBL] [Abstract][Full Text] [Related]
8. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts. Huang JS; Chuang LY; Guh JY; Chen CJ; Yang YL; Chiang TA; Hung MY; Liao TN J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation. Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins. Shi H; Zhang T; Yi Y; Ma Y Oncol Rep; 2016 Jun; 35(6):3593-9. PubMed ID: 27004682 [TBL] [Abstract][Full Text] [Related]
12. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. Wang Z; Wang M; Carr BI J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308 [TBL] [Abstract][Full Text] [Related]
13. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. Osada S; Saji S; Osada K Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961 [TBL] [Abstract][Full Text] [Related]
14. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
15. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines. Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923 [TBL] [Abstract][Full Text] [Related]
16. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK/ERK activation in thyroid epithelial cells. Montiel M; Quesada J; Jiménez E Cell Signal; 2007 Oct; 19(10):2138-46. PubMed ID: 17643958 [TBL] [Abstract][Full Text] [Related]
17. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells. Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605 [TBL] [Abstract][Full Text] [Related]
18. Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Chen YC; Ren F; Sang JR; Tao Y; Xu WR Mol Med Rep; 2010; 3(2):361-6. PubMed ID: 21472248 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211 [TBL] [Abstract][Full Text] [Related]
20. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Zhang T; Ma J; Cao X Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]